A study on liver transplant for different liver diseases
Part of Digestive system clinical trials.
This trial is testing a new way to see how well patients do after a liver transplant. It includes people with severe cirrhosis, other end-stage liver diseases, or liver cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old
- You need to be listed for a liver transplant because of serious liver damage, cancer, or other end-stage liver disease
- You must be on a national waiting list for a liver from a deceased donor
- You or a trusted person must agree and sign a consent form
- You cannot have cancer that has spread outside the liver or into major blood vessels
- Pregnant or nursing women cannot take part
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects data from adults listed for liver transplants due to severe liver disease or liver cancer. It aims to improve transplant care by learning from real-world patient information.
This trial looks at liver transplant for people with advanced intrahepatic cholangiocarcinoma (a bile duct cancer inside the liver) when the cancer is not safely removable and stays controlled. It may help some patients live longer and with better quality of life by replacing the diseased liver—if strict safety and disease-stability requirements are met.
This trial tests a new way to preserve donated livers before transplant, which may help people with severe liver disease get a transplant sooner. It may be an option for patients with certain cancers or urgent liver failure.
This study is looking at whether a liver transplant can help people who have liver cancer that has spread into the bile ducts, which are the tubes that carry bile from the liver. We want to see if this surgery is safe and how well it works for these patients.
This study looks at when liver transplant is offered and what outcomes happen in people with cirrhosis who have severe “acute-on-chronic” worsening. It may help doctors decide which patients benefit most from transplant and improve care after listing or not listing.
This study tests whether giving a liver transplant to people with cirrhosis and small liver tumors from hepatitis B can help them live longer. It compares outcomes for patients who meet specific tumor size criteria.
Hear when a new Decompensated Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.